Citations

Showing 10 of 108094 citations.

Evaluation of Disorders of Blood Coagulation in the Clinical Laboratory
Owen, Charles A., Hurn, Margaret, Stickney, J.M., Mann, Frank D.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 25 | Issue: 12_ts | Pages: 1417-1426

10.1093/ajcp/25.12_ts.1417 | PMID 13268375 Get It

A Syringe Envelope
Magath, Thomas B.

Mayo Clinic

American Journal of Clinical Pathology | February 12, 2018 | Volume: 23 | Issue: 1_ts | Pages: 100-100

10.1093/ajcp/23.1_ts.100 | PMID 13016513 Get It

Nanoparticle-Mediated Cell Capture Enables Rapid Endothelialization of a Novel Bare Metal Stent
Tefft, Brandon J. , Uthamaraj, Susheil , Harbuzariu, Adriana , Harburn, J. Jonathan, Witt, Tyra A. , Newman, B., Psaltis, Peter J. , Hlinomaz, Ota , Holmes, David R. , Gulati, Rajiv , Simari, Robert D., Dragomir‐Daescu, Dan , Sandhu, Gurpreet S. , Newman, Brant

Mayo Clinic

Tissue Engineering Part A | February 12, 2018 | Volume: 24 | Issue: 13-14 | Pages: 1157-1166

10.1089/ten.tea.2017.0404 | PMID 29431053 Get It

Medial Patellofemoral Ligament Reconstruction Using All‐Soft Suture Anchors for Patellar Fixation
Makovicka, Justin L. , Hartigan, David E. , Patel, Karan A. , Patel, Karan , Tummala, Sailesh V. , Chhabra, Anikar , Tummala, Sailesh V

Mayo Clinic

Arthroscopy Techniques | February 12, 2018 | Volume: 7 | Issue: 3 | Pages: No page available

10.1016/j.eats.2017.08.075 | PMID 29881694 Get It

Abstract The medial patellofemoral ligament (MPFL), which is critical for both patellar stability and normal kinematics of the patellofemoral joint, is disrupted in most patellar dislocations. Consequently, MPFL reconstruction is advocated in recurrent dislocations to restore native patellar constraints. Fixation of the MPFL graft to the medial border of the patella can be achieved through various methods, each with its own benefits and drawbacks. We present a technique for MPFL fixation to the patella using all‐soft suture anchors, theoretically decreasing the risk of patellar fracture and articular surface violation. Technique Video video See video under supplementary data.
Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia
Iyer, Vivek , Brinjikji, Waleed , Apala, Dinesh , Pannu, Bibek , Kotecha, Aditya , Leise, Michael D. , Kamath, Patrick S. , Misra, Sanjay , Krowka, Michael J. , Wood, Christopher P. , Swanson, Karen L., Iyer, Vivek N , Pannu, Bibek S, Misra, Sanjay , Lanzino, Giuseppe

Mayo Clinic

Advances in Hematology | February 11, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-8

10.1155/2018/4798425 | PMID 29610574 Get It

Background. There is little published literature regarding the impact of age on outcomes amongst hospitalized HHT (hereditary hemorrhagic telangiectasia) patients. Methods. The Nationwide Inpatient Sample (NIS) was used to obtain data on all hospital discharges occurring in HHT patients from 2000 to 2012. The association between admission age and HHT-related complications and outcomes were studied. Results. 10293 hospitalizations in HHT patients from 2000 to 2012 were included. Patients > 50 accounted for 77% of all admissions with 30% of admissions occurring in the 51–65 age group. Bleeding related complications were the most frequent (62.7%, n=6455 hospitalizations), followed by cardiovascular (41%, n=4216), neurological (12.4%, n=1276), and hepatobiliary (6.4%, n=660) complications. Patients older than 50 accounted for 83% of bleeding events, 90% of cardiovascular events, 58% of neurologic events, and 81% of hepatobiliary events. The vast majority (83%) of medical and surgical procedures were performed in those older than 50 years of age. Older patients also experienced higher rates of death. Conclusion. Aging has significant adverse impacts on rates of hospitalization, complications, and outcomes amongst HHT patients in the United States. Except for neurologic complications, the vast majority of this disease burden is borne by patients older than 50 years.
Examination of Utricular Response Using oVEMP and Unilateral Centrifugation Rotation Testing
Zalewski, Christopher , Ackley, R. Steven, McCaslin, Devin L. , Clark, M. Diane , Hanks, Wendy D., Brewer, Carmen C.

Mayo Clinic

Ear & Hearing | February 11, 2018 | Volume: 39 | Issue: 5 | Pages: 910-921

10.1097/aud.0000000000000552 | PMID 29432406 Get It

Objectives: Significant advancements have been made toward the clinical assessment of utricular function through ocular vestibular-evoked myogenic potentials (oVEMP) and unilateral centrifugation (UCF) testing. To date, no study has examined intrasubject relationships between these measures. The study hypothesis was that intrasubject responses from oVEMP and UCF testing would be correlated inasmuch as both tests have been reported to assess utricular function. Design: UCF rotations and oVEMP testing were performed on healthy volunteers, aged 18 to 62 years. A within-subject study design compared and correlated UCF outcome measures of ocular counterroll, subjective visual vertical, and ocular counterroll–gravitational inertial acceleration slope against peak to peak oVEMP N1–P1 amplitude. Results: Correlational analyses failed to reveal any significant relationships between oVEMP amplitude and UCF responses suggesting that these tests may be inciting different response properties within the utricular system. Conclusions: Various anatomical and physiological differences within the utricle, in addition to the fundamental differences in stimulus properties between the oVEMP and UCF tests, could explain the lack of significant correlations between these measures and suggest that oVEMP and UCF testing may be complimentary in their evaluation of the utricular system. These data reinforce the complexities of the utricular system and provide further insight into the difficulties encountered in its clinical assessment.
A monoclonal antibody against SV40 large T antigen (PAb416) does not label Merkel cell carcinoma
Pelletier, Daniel , Czeczok, Thomas , Bellizzi, Andrew M. , Czeczok, Thomas W, Bellizzi, Andrew M

Mayo Clinic

Histopathology | February 11, 2018 | Volume: 73 | Issue: 1 | Pages: 162-166

10.1111/his.13483 | PMID 29430700 Get It

AimsMerkel cell carcinoma represents poorly differentiated neuroendocrine carcinoma of cutaneous origin. In most studies, the vast majority of Merkel cell carcinomas are Merkel cell polyomavirus (MCPyV)‐associated. SV40 polyomavirus immunohistochemistry is typically used in the diagnosis of other polyomavirus‐associated diseases, including tubulointerstitial nephritis and progressive multifocal leukoencephalopathy, given cross‐reactivity with BK and JC polyomaviruses. MCPyV‐specific immunohistochemistry is commercially available, but, if antibodies against SV40 also cross‐reacted with MCPyV, that would be advantageous from a resource‐utilisation perspective.Methods and resultsTissue microarrays were constructed from 39 Merkel cell carcinomas, 24 small‐cell lung carcinomas, and 18 extrapulmonary visceral small‐cell carcinomas. SV40 large T antigen immunohistochemistry (clone PAb416) was performed; MCPyV large T antigen immunohistochemistry (clone CM2B4) had been previously performed. UniProt was used to compare the amino acid sequences of the SV40, BK, JC and MCPyV large T antigens, focusing on areas recognised by the PAb416 and CM2B4 clones. SV40 immunohistochemistry was negative in all tumours; MCPyV immunohistochemistry was positive in 38% of Merkel cell carcinomas and in 0% of non‐cutaneous poorly differentiated neuroendocrine carcinomas. UniProt analysis revealed a high degree of similarity between SV40, BK, and JC viruses in the region recognised by PAb416. There was less homology between SV40 and MCPyV in this region, which was also interrupted by two long stretches of amino acids unique to MCPyV. The CM2B4 clone recognises a unique epitope in one of these stretches.ConclusionsThe PAb416 antibody against the SV40 large T antigen does not cross‐react with MCPyV large T antigen, and thus does not label Merkel cell carcinoma.
Safety of Laser Interstitial Thermal Therapy in Patients With Pacemakers
Gorny, Krzysztof R. , Favazza, Christopher , Watson, Robert E. , Favazza, Christopher P, Grewal, Sanjeet S. , Kaufmann, Timothy J. , Gompel, Jamie J. Van

Mayo Clinic

Operative Neurosurgery | February 10, 2018 | Volume: 15 | Issue: 5 | Pages: E69-E72

10.1093/ons/opx292 | PMID 29444267 Get It

Abstract BACKGROUND AND IMPORTANCE Laser interstitial thermal therapy (LiTT) has increasingly been used as a treatment option for medically refractory epilepsy, tumors, and radiation necrosis. The use of LiTT requires intraoperative magnetic resonance (MR) thermography. This can become an issue in patients with other implanted therapeutic devices such as pacemakers and vagal nerve stimulators due to concerns regarding increases in the specific absorption rate (SAR). This is a technical case report demonstrating a successfully and safely performed LiTT in a 1.5-T magnetic resonance imaging (MRI) in a patient with a pacemaker for mesial temporal sclerosis. CLINICAL PRESENTATION An 83-yr-old gentleman who had an implanted cardiac pacemaker presented with medically intractable epilepsy and was confirmed to have mesial temporal sclerosis on imaging. Video electroencephalography demonstrated concordant ipsilateral seizures and semiology. He underwent LiTT for ablation of the mesial temporal lobe. This was performed with the below described protocol with a cardiology nurse monitoring the patient's cardiac condition and a physicist monitoring SAR, and MR imaging quality without any adverse events. CONCLUSION This study reports on a protocol of cardiac and MR SAR to safely perform MR-guided LiTT in the setting of traditional pacemakers in patients who are not pacemaker dependent.
Evaluation of a Reagent-Impregnated Strip for Detection of Nitrate Reduction by Bacterial Isolates
Yu, Pauline K. W., Birk, Robert J., Washington, John A.

Mayo Clinic

American Journal of Clinical Pathology | February 10, 2018 | Volume: 52 | Issue: 6_ts | Pages: 791-793

10.1093/ajcp/52.6_ts.791 Get It

Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy
Snozek, Christine L.H. , Kinard, Theresa N. , Adamski, Jill

Mayo Clinic

Journal of Clinical Apheresis | February 10, 2018 | Volume: 33 | Issue: 3 | Pages: 439-443

10.1002/jca.21619 | PMID 29427353 Get It

ABSTRACTThis report describes a patient with light chain myeloma and acute renal injury. Serum kappa free light chain (FLC) was extremely elevated, >33,000 mg/dL. Treatment with therapeutic plasma exchange (TPE) started day 2 for biopsy‐confirmed cast nephropathy. Bortezomib‐containing chemotherapy was initiated on day 5, and hemodialysis for tumor lysis syndrome on day 7. TPE alone decreased kappa FLC >70% by day 5, indicating direct FLC removal was successful in this patient. A total of 25 TPE procedures were performed in a 31‐day hospitalization. Hemodialysis was discontinued after 3 months, and the patient's renal function and kappa FLC remain stable. Although the use of TPE for FLC removal is controversial, recent evidence supports its use as adjuvant therapy for acute renal injury secondary to myeloma cast nephropathy. TPE can be effective for rapidly reducing FLC; however, several TPE procedures might be required to reduce the risk of hemodialysis dependency.